Hypogonadal Patients with Crohn's Disease Benefit from Treatment with Testosterone – Further Data from an Ongoing, Long-Term, Observational Registry Study

Trial Profile

Hypogonadal Patients with Crohn's Disease Benefit from Treatment with Testosterone – Further Data from an Ongoing, Long-Term, Observational Registry Study

Completed
Phase of Trial: Phase IV

Latest Information Update: 24 Aug 2015

At a glance

  • Drugs Testosterone undecanoate (Primary)
  • Indications Crohn's disease; Hypogonadism
  • Focus Therapeutic Use
  • Sponsors Bayer
  • Most Recent Events

    • 24 Aug 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top